Delivery Order SPE2DB24D1201-SPE2DB25FJDWE
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $4,881.13 firm fixed-price delivery order from the Defense Logistics Agency on August 11, 2025, for Jardiance 25 mg tablets (90-count supply). The contract, which is non-set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $18,630.72 by the Defense Logistics Agency (DLA) for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was issued on August 11, 2025, under a non-set-aside procurement. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,488.53 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by August 12, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $2,348.15. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,578.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $4,328.80 and an ultimate completion date of August 8, 2025. This award represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDWEDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90-count bottles of Jardiance 10 mg tablets, valued at $22,225.71. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation and represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government's medical procurement infrastructure. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Jardiance order reflects the company's role as a critical vendor for diabetes management medications and other therapeutic pharmaceuticals within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.2k | 8/11/25 |